166 related articles for article (PubMed ID: 36748953)
1. Targeting lipid metabolism with natural products: A novel strategy for gastrointestinal cancer therapy.
Guo C; Zhang L; Zhao M; Ai Y; Liao W; Wan L; Liu Q; Li S; Zeng J; Ma X; Tang J
Phytother Res; 2023 May; 37(5):2036-2050. PubMed ID: 36748953
[TBL] [Abstract][Full Text] [Related]
2. Pull the plug: Anti-angiogenesis potential of natural products in gastrointestinal cancer therapy.
Ai Y; Zhao Z; Wang H; Zhang X; Qin W; Guo Y; Zhao M; Tang J; Ma X; Zeng J
Phytother Res; 2022 Sep; 36(9):3371-3393. PubMed ID: 35871532
[TBL] [Abstract][Full Text] [Related]
3. Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy.
Tewari D; Patni P; Bishayee A; Sah AN; Bishayee A
Semin Cancer Biol; 2022 May; 80():1-17. PubMed ID: 31866476
[TBL] [Abstract][Full Text] [Related]
4. Effect of Inonotus obliquus (Fr.) Pilat extract on the regulation of glycolipid metabolism via PI3K/Akt and AMPK/ACC pathways in mice.
Zhang Z; Liang X; Tong L; Lv Y; Yi H; Gong P; Tian X; Cui Q; Liu T; Zhang L
J Ethnopharmacol; 2021 Jun; 273():113963. PubMed ID: 33640441
[TBL] [Abstract][Full Text] [Related]
5. Phytochemicals and Nanoparticles in the Modulation of PI3K/Akt/mTOR Kinases and its Implications in the Development and Progression of Gastrointestinal Cancers: A Review of Preclinical and Clinical Evidence.
Narayanankutty A; Nambiattil S; Mannarakkal S
Recent Pat Anticancer Drug Discov; 2023; 18(3):307-324. PubMed ID: 35670354
[TBL] [Abstract][Full Text] [Related]
6. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism.
Dai W; Xiang W; Han L; Yuan Z; Wang R; Ma Y; Yang Y; Cai S; Xu Y; Mo S; Li Q; Cai G
Cancer Commun (Lond); 2022 Sep; 42(9):848-867. PubMed ID: 35904817
[TBL] [Abstract][Full Text] [Related]
7. MC-LR Aggravates Liver Lipid Metabolism Disorders in Obese Mice Fed a High-Fat Diet via PI3K/AKT/mTOR/SREBP1 Signaling Pathway.
Chu H; Du C; Yang Y; Feng X; Zhu L; Chen J; Yang F
Toxins (Basel); 2022 Nov; 14(12):. PubMed ID: 36548730
[TBL] [Abstract][Full Text] [Related]
8. PI3K-AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds.
Yuan Y; Long H; Zhou Z; Fu Y; Jiang B
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671478
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory Potential of Dietary Nutraceuticals on Cellular PI3K/Akt Signaling: Implications in Cancer Prevention and Therapy.
Narayanankutty A
Curr Top Med Chem; 2021; 21(20):1816-1831. PubMed ID: 34279200
[TBL] [Abstract][Full Text] [Related]
10. Berberine Exerts Anti-cancer Activity by Modulating Adenosine Monophosphate- Activated Protein Kinase (AMPK) and the Phosphatidylinositol 3-Kinase/ Protein Kinase B (PI3K/AKT) Signaling Pathways.
Huang J; Feng W; Li S; Tang H; Qin S; Li W; Gong Y; Fang Y; Liu Y; Wang S; Guo Y; Xu Z; Shen Q
Curr Pharm Des; 2021; 27(4):565-574. PubMed ID: 32988344
[TBL] [Abstract][Full Text] [Related]
11. Targeting SREBP-1-driven lipid metabolism to treat cancer.
Guo D; Bell EH; Mischel P; Chakravarti A
Curr Pharm Des; 2014; 20(15):2619-26. PubMed ID: 23859617
[TBL] [Abstract][Full Text] [Related]
12. Central role of SREBP-2 in the pathogenesis of osteoarthritis.
Kostopoulou F; Gkretsi V; Malizos KN; Iliopoulos D; Oikonomou P; Poultsides L; Tsezou A
PLoS One; 2012; 7(5):e35753. PubMed ID: 22662110
[TBL] [Abstract][Full Text] [Related]
13. Targeting the PI3K/AKT/mTOR Signaling Pathway in Lung Cancer: An Update Regarding Potential Drugs and Natural Products.
Iksen ; Pothongsrisit S; Pongrakhananon V
Molecules; 2021 Jul; 26(13):. PubMed ID: 34279440
[TBL] [Abstract][Full Text] [Related]
14. Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy.
Chamcheu JC; Roy T; Uddin MB; Banang-Mbeumi S; Chamcheu RN; Walker AL; Liu YY; Huang S
Cells; 2019 Jul; 8(8):. PubMed ID: 31370278
[TBL] [Abstract][Full Text] [Related]
15. Natural products attenuate PI3K/Akt/mTOR signaling pathway: A promising strategy in regulating neurodegeneration.
Fakhri S; Iranpanah A; Gravandi MM; Moradi SZ; Ranjbari M; Majnooni MB; Echeverría J; Qi Y; Wang M; Liao P; Farzaei MH; Xiao J
Phytomedicine; 2021 Oct; 91():153664. PubMed ID: 34391082
[TBL] [Abstract][Full Text] [Related]
16. Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy.
Xu Z; Han X; Ou D; Liu T; Li Z; Jiang G; Liu J; Zhang J
Appl Microbiol Biotechnol; 2020 Jan; 104(2):575-587. PubMed ID: 31832711
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
[TBL] [Abstract][Full Text] [Related]
18. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease.
Du C; Wu M; Liu H; Ren Y; Du Y; Wu H; Wei J; Liu C; Yao F; Wang H; Zhu Y; Duan H; Shi Y
Int J Biochem Cell Biol; 2016 Oct; 79():1-13. PubMed ID: 27497988
[TBL] [Abstract][Full Text] [Related]
19. The Akt-SREBP nexus: cell signaling meets lipid metabolism.
Krycer JR; Sharpe LJ; Luu W; Brown AJ
Trends Endocrinol Metab; 2010 May; 21(5):268-76. PubMed ID: 20117946
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase Cε Regulates Prostate Cancer Lipid Metabolism and Proliferation by Targeting AMP-Activated Protein Kinase (AMPK)/Sterol Regulatory Element-Binding Protein 1 (SREBP-1) Signaling Pathway.
Zheng Y; Jin J; Gao Y; Luo C; Wu X; Liu J
Med Sci Monit; 2020 Jul; 26():e924328. PubMed ID: 32696762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
